
A 5-Question Quiz on Pediatric Hematologic Cancers
In the first blinatumomab trial, what percentage of pediatric ALL patients achieved a complete remission? What is the effect of vitamin D and calcium supplementation on bone mineral density in the pediatric ALL population? Test your knowledge in our latest quiz.
In the first blinatumomab trial, what percentage of pediatric acute lymphoblastic leukemia (ALL) patients achieved a complete remission? And what is the effect of vitamin D and calcium supplementation on bone mineral density in the pediatric ALL population? Test your knowledge in our latest quiz.
Question 1
Answer
D. cMpl
Granulocyte macrophase progenitor predominance in CML progenitors at diagnosis may also predict poor outcome, according to a
Question 2
Answer
A. 15- to 21-year-olds
Patients in this age group were significantly less likely to use CCC/COG sites than children (P < .001), according to the
Question 3
Answer
A. BMD scores decreased in the first 2 years, then increased
“Vitamin D and calcium supplementation in pediatric ALL patients during intensive chemotherapy may not prevent bone mineral loss, ” according to the
Question 4
Answer
B. Sticker reminders on treatment road maps
“Our efforts are now being directed at improving screening and interventions prior to day 8,” the investigators of the
Question 5
Answer
B. 39%
Among the 70 patients who received the recommended dose of blinatumomab, 27 patients (39%) achieved complete remission within the first 2 cycles. Of those, 14 (52%) had minimal residual disease response, the authors of the
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.